-
公开(公告)号:US20240252654A1
公开(公告)日:2024-08-01
申请号:US18252083
申请日:2021-10-19
发明人: Alessio Ciulli , Andrea Testa , Chiara Maniaci , Nikolai Makukhin , Satomi Imaide , Danette Daniels , Kristin Riching
摘要: This invention particularly relates to trifunctional PROTACs of formula I as described herein which bind to a protein within the Bromo- and Extra-Terminal (BET) family of proteins, and especially to PROTACs including small molecule E3 ubiquitin ligase protein binding ligand compounds which induce preferential degradation of the BRD2 protein within the bromodomain of the BET family of proteins.
-
公开(公告)号:US20220127257A1
公开(公告)日:2022-04-28
申请号:US17567280
申请日:2022-01-03
申请人: University of Dundee
发明人: Alessio Ciulli , Chiara Maniaci , Scott J. Hughes , Andrea Testa
IPC分类号: C07D417/14
摘要: Compounds having the general structure A-L-B are presented wherein A and B are independently an E3 ubiquitin ligase protein binding ligand compound of formula 1A or 1B. Pharmaceutical compositions comprising these compounds and methods of use are also presented.
-
3.
公开(公告)号:US11234988B2
公开(公告)日:2022-02-01
申请号:US16333454
申请日:2017-09-14
申请人: UNIVERSITY OF DUNDEE
发明人: Alessio Ciulli , Andrea Testa
IPC分类号: C07D207/00 , A61K31/551 , A61K47/54 , A61K47/55 , A61K31/4709 , A61K45/06 , C07D207/46 , C07D417/12 , C07D417/14 , C07D495/14 , C07D207/16 , C07K5/062 , C07K5/087 , A61K31/427
摘要: There is provided novel small molecule E3 ubiquitin ligase protein binding ligand compounds, and to their utility in PROteolysis Targeted Chimeras (PROTACs), as well as processes for their preparation thereof, and use in medicine. There is particularly provided novel small molecule E3 ubiquitin ligase protein binding inhibitor compounds based on a fluorohydroxyproline scaffold, to their utility as ligands in synthesizing novel PROTACs, and to synthetic methods therefor.
-
公开(公告)号:US20210163469A1
公开(公告)日:2021-06-03
申请号:US16604737
申请日:2018-04-13
申请人: University of Dundee
发明人: Alessio Ciulli , Chiara Maniaci , Scott J. Hughes , Andrea Testa
IPC分类号: C07D417/14
摘要: Compounds having the general structure A-L-B are presented wherein A and B are independently an E3 ubiquitin ligase protein binding ligand compound of formula 1A or 1B. Pharmaceutical compositions comprising these compounds and methods of use are also presented.
-
公开(公告)号:US11261179B2
公开(公告)日:2022-03-01
申请号:US16604737
申请日:2018-04-13
申请人: University of Dundee
发明人: Alessio Ciulli , Chiara Maniaci , Scott J. Hughes , Andrea Testa
IPC分类号: C07D417/14
摘要: Compounds having the general structure A-L-B are presented wherein A and B are independently an E3 ubiquitin ligase protein binding ligand compound of formula 1A or 1B. Pharmaceutical compositions comprising these compounds and methods of use are also presented.
-
-
-
-